• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH Back to Search Results
Catalog Number 306572
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/20/2020
Event Type  malfunction  
Manufacturer Narrative
"multiple lot numbers: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 0126426 medical device expiration date: 2023-04-30 device manufacture date: 2020-05-05 medical device lot #: 01267451 was reported, however, this is not lot# manufactured by bd." a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that after use with a bd posiflush¿ xs pre-filled flush syringe nacl 0.9% white foreign matter was discovered in tube.The following information was provided by the initial reporter, translated from french to english: 19/08 at 17:00; laying of a picc line perfusion on picc line on 19/08: 1 litre nacl 0, 9% started at 5.18pm + pantoprawole 40mg iv at 7.16pm.(b)(6) morning; appearance of white particles in pre-filled nacl syringes when rinsing the piccline for sampling.White particles also present in the sample tube.(on photo= particle at the level of coagulated blood) - syringe not conserved.Perfusion on piccline on (b)(6); 1 litre nacl 0.9% started at 15h30+ pantoprazale 40mg iv at 19h44 (b)(6) morning; test a new sample = whitish deposits in the syringe.A 2nd photo taken several hours after sampling - particle less visible on the photo- visually observing a larger deposit than the day before.Syringe kept batch 0126426- references other dms used: infusion set ref.Infusion set 1fl25 ( gel: 760070) nacl 0,9% 1litre : lot 19j07h and 20b054 ( gef: 521535) reference pantoprazole iv 40mg : lot not kept several in stock additionally, on 2020-08-31 the bd sales consultant provided the following additional information: could you please describe the action taken following this incident? quarantined batch of syringes.What were the consequences on your operation? did not concern a surgical operation but a sample, nothing to add, sample taken and results transmitted.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes.D.10.Returned to manufacturer on: 9/14/2020.H.6.Investigation: a device history record review was performed for provided lot numbers 0126426 and 0167451 and the review did not reveal any detected quality issues during the production process that could have contributed to this reported incident.To aid in the investigation of this issue, both picture and physical samples were returned for evaluation by our quality engineer team.One physical sample belonging to lot number 0126426 was returned and through examination of the sample, the syringe was observed contaminated with blood.Five samples were returned for lot number 0167451.Two of the samples contained blood and the remaining three samples appeared free of any foreign contaminates within the saline.Based on the investigation results, the reported incident could not be substantiated and an exact cause could not be determined.Through examination of the samples and the provided information, it is possible that misuse of the product occurred.The posiflush syringes are pre-filled single use syringes intended for flushing only.Pre-filled and conventional syringes have different purposes.
 
Event Description
It was reported that after use with a bd posiflush¿ xs pre-filled flush syringe nacl 0.9% white foreign matter was discovered in tube.The following information was provided by the initial reporter, translated from french to english: 19/08 at 17:00; laying of a picc line perfusion on picc line on 19/08: 1 litre naci 0, 9% started at 5.18pm + pantoprawole 40mg iv at 7.16pm.20/08 morning; appearance of white particles in pre-filled nacl syringes when rinsing the piccline for sampling.White particles also present in the sample tube.( on photo= particle at the level of coagulated blood) - syringe not conserved.Perfusion on piccline on 20/08; 1 litre nacl 0.9% started at 15h30+ pantoprazale 40mg iv at 19h44 21/08 morning; test a new sample = whitish deposits in the syringe.A 2nd photo taken several hours after sampling - particle less visible on the photo- visually observing a larger deposit than the day before.Syringe kept batch 0126426- references other dms used: infusion set ref.Infusion set 1fl25 ( gel: 760070) -nacl 0,9% 1litre : lot 19j07h and 20b054 ( gef: 521535) reference pantoprazole iv 40mg : lot not kept several in stock additionally, on 2020-08-31 the bd sales consultant provided the following additional information: - could you please describe the action taken following this incident? quarantined batch of syringes - what were the consequences on your operation? did not concern a surgical operation but a sample, nothing to add, sample taken and results transmitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH XS PRE-FILLED FLUSH SYRINGE NACL 0.9%
Type of Device
SALINE VASCULAR ACCESS FLUSH
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key10547837
MDR Text Key216391883
Report Number9616657-2020-00152
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 09/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number306572
Device Lot NumberSEE H.10
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/14/2020
Initial Date Manufacturer Received 08/25/2020
Initial Date FDA Received09/17/2020
Supplement Dates Manufacturer Received08/25/2020
Supplement Dates FDA Received09/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-